Validation of the LC-MS/MS method for the quantification of mevalonic acid in human plasma and determination of the matrix effect

Journal of Lipid Research

Volumn 47, Issue 10, 2006, Pages 2340-2345

  Saini, G S ^a   Wani, T A ^b   Gautam, A ^a   Varshney, B ^a   Ahmed, T ^a   Rajan, K S ^a   Pillai, K K ^b   Paliwal, J K ^a  

^a RANBAXY RESEARCH LABORATORIES   (India)

^b HAMDARD UNIVERSITY   (India)

Author keywords

Biomarker; Liquid chromatography tandem mass spectrometry; Statin

Indexed keywords

MEVALONIC ACID; MEVALONOLACTONE; ROSUVASTATIN;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; VALIDATION STUDY;

ANIMALS; ARTIFACTS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FLUOROBENZENES; HUMANS; MASS SPECTROMETRY; MEVALONIC ACID; MODELS, MOLECULAR; PYRIMIDINES; RATS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SULFONAMIDES;

EID: 33845580447     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.D600018-JLR200     Document Type: Article

References (16)

1. Parker, T. S., D. J. McNamara, C. D. Brown, R. Kolb, E. H. Ahrens, J. Tobert, and P. J. DeSchepper. 1984. Plasma mevalonate as a measure of cholesterol synthesis in man. J. Clin. Invest. 74: 795-804.
2. Popljak, G., C. Boehm, T. S. Parker, J. Edmond, P. A. Edwards, and D. A. Fogelman. 1979. Determination of'mevalonate in blood plasma in man and rat. Mevalonate tolerance tests in man. J. Lipid Res. 20: 716-728.
3. Yoshida, T., A. Honda, N. Tanaka, Y. Matsuzaki, B. He, T. Osuga, N. Kobayashi, K. Ozawa, and H. Miyazaki. 1993. Simultaneous determination of mevalonate and 7 alpha-hydroxycholesterol in human plasma by gas chromatography-mass spectrometry as indices of cholesterol and bile acid biosynthesis. J. Chromatogr. 613: 185-193.
4. Scoppola, A., V. M. Maher, G. R. Thompson, N. B. Rendell, and G. W. Taylor. 1991. Quantitation of plasma mevalonic acid using gas chromatography-electron capture mass spectrometry. J. Lipid Res. 32: 1057-1060.
5. Naoumova, R. P., S. Dunn, L. Rallidis, O. A. Muhana, C. Neuwirth, N. B. Rendell, G. W. Taylor, and G. R. Thompson. 1997. Prolonged inhibition of cholesterol synthesis explains the efficacy of atorvastatin. J. Lipid Res. 38: 1496-1500.
6. O'Neill, F. H., D. D. Patel, B. L. Knight, C. K. Neuwirth, M. Bourbon, A. K. Soutar, G. W. Taylor, G. R. Thompson, and R. P. Naoumova. 2001. Determinants of variable response to statin treatment in patients with refractory familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 21: 832-837.
7. Makoto, H., H. Akio, H. Hideki, U. Hirotsugu, and K. Takashi. 1998. Enzyme immunoassay of urinary mevalonic acid and its clinical application. Clin. Chem. 44: 2152-2157.
8. Hangerfeldt, L., and K. Hellstrom. 1972. Blood concentration and turnover of circulating mevalonate in the rat. Life Sci. 11: 669-676.
9. Siavoshian, S., C. Simoneau, P. Maugeais, L. Marks, L. Rodary, J. Gardette, and M. Krempf. 1995. Measurement of mevalonic acid in human urine by bench top gas chromatography-mass spectrometry. Clin. Chim. Acta. 243: 129-136.
10. Woollen, B. H., P. C. Holme, W. J. Northway, and P. D. Martin. 2001. Determination of mevalonic acid in human urine as mevalonic acid lactone by gas chromatography-mass spectrometry. J. Chromatogr. B. 760: 179-184.
11. Abrar, M., and P. D. Martin. 2002. Validation and application of an assay for the determination of mevalonic acid in human plasma by liquid chromatography tandem mass spectrometry. J. Chromatogr. B. 773: 103-111.
12. Jemal, M., A. Schuster, and D. B. Whigan. 2003. Liquid chromatography/tandem mass spectrometry methods for quantitation of mevalonic acid in human plasma and urine: method validation, demonstration of using a surrogate analyte, and demonstration of unacceptable matrix effect in spite of use of a stable isotope analog internal standard. Rapid Commun. Mass Spectrom. 17: 1723-1734.
13. Naoumova, R. P., A. D. Marais, J. Mountney, J. C. Firth, N. B. Rendell, G. W. Taylor, and G. R. Thompson. 1996. Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMGCoA reductase inhibitors in familial hypercholesterolaemia. Atherosclerosis. 119: 203-213.
14. Martin, P. D., P. D. Mitchell, and D. W. Schneck. 2002. Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning and evening administration in healthy volunteers. Br. J. Clin. Pharmacol. 54: 472-477.
15. Lindenthal, B., and K. Von Bergmann. 2000. Urinary excretion and serum concentration of mevalonic acid during acute intake of alcohol. Metabolism. 49: 62-66.
16. Kopito, R. R., S. B. Weinstock, L. E. Freed, D. M. Murray, and H. Brunengraber. 1982. Metabolism of plasma mevalonate in rats and humans. J. Lipid Res. 23: 577-583.